SanyouBio is a biological high-tech enterprises majorly committed to innovative therapeutic monoclonal antibody development and services.
It was established in Shanghai in May 2015, and has invested totally more than 20 million yuan. In the state-level economic and technological development zone "Shanghai Caohejing Hi-tech Park ", SanyouBio has the established innovative antibody R & D platform with thousands of square meters, equipped facilities and advanced technology platforms including "comprehensive protein expression and antigen preparation", "diversified methods of antibody generation", "the ultra-comprehensive antibody engineering", "systemic in vitro efficacy and functional screening for therapeutic antibody", "efficient medicinal evaluation of therapeutic antibody", "integration of innovative therapeutic monoclonal antibody discovery " and many other international-advanced technologies and sub-platforms. Now it is committed to building preclinical technology platforms for drug discovery with international standard.